{"id":"https://openalex.org/W4376643288","doi":"https://doi.org/10.1073/pnas.2221967120","title":"Design of rigid protein\u2013protein interaction inhibitors enables targeting of undruggable Mcl-1","display_name":"Design of rigid protein\u2013protein interaction inhibitors enables targeting of undruggable Mcl-1","publication_year":2023,"publication_date":"2023-05-15","ids":{"openalex":"https://openalex.org/W4376643288","doi":"https://doi.org/10.1073/pnas.2221967120","pmid":"https://pubmed.ncbi.nlm.nih.gov/37186857","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10214187"},"language":"en","primary_location":{"id":"doi:10.1073/pnas.2221967120","doi":"https://doi.org/10.1073/pnas.2221967120","is_oa":true,"landing_page_url":"https://doi.org/10.1073/pnas.2221967120","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1073/pnas.2221967120","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043016182","display_name":"David Hargreaves","orcid":"https://orcid.org/0000-0003-4441-0039","observed_orcids":["https://orcid.org/0000-0003-4441-0039"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Hargreaves","raw_affiliation_strings":["Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025208579","display_name":"Rodrigo J. Carbajo","orcid":"https://orcid.org/0000-0002-0312-6499","observed_orcids":["https://orcid.org/0000-0002-0312-6499"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rodrigo J. Carbajo","raw_affiliation_strings":["Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0312-6499","affiliations":[{"raw_affiliation_string":"Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004157917","display_name":"Michael S. Bodnarchuk","orcid":"https://orcid.org/0000-0002-9172-1203","observed_orcids":["https://orcid.org/0000-0002-9172-1203"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael S. Bodnarchuk","raw_affiliation_strings":["Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036255361","display_name":"Kevin J. Embrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin Embrey","raw_affiliation_strings":["Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053808561","display_name":"Philip B. Rawlins","orcid":"https://orcid.org/0000-0002-1595-5550","observed_orcids":["https://orcid.org/0000-0002-1595-5550"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Philip B. Rawlins","raw_affiliation_strings":["Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Sciences, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Martin Packer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Packer","raw_affiliation_strings":["Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010517370","display_name":"S\u00e9bastien L. Degorce","orcid":"https://orcid.org/0000-0002-9478-5106","observed_orcids":["https://orcid.org/0000-0002-9478-5106"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S\u00e9bastien L. Degorce","raw_affiliation_strings":["Discovery Sciences, AstraZeneca, Waltham, MA 02451"],"raw_orcid":"https://orcid.org/0000-0002-9478-5106","affiliations":[{"raw_affiliation_string":"Discovery Sciences, AstraZeneca, Waltham, MA 02451","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070605323","display_name":"Alexander W. Hird","orcid":"https://orcid.org/0000-0002-2699-7449","observed_orcids":["https://orcid.org/0000-0002-2699-7449"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander W. Hird","raw_affiliation_strings":["Discovery Sciences, AstraZeneca, Waltham, MA 02451"],"raw_orcid":"https://orcid.org/0000-0002-2699-7449","affiliations":[{"raw_affiliation_string":"Discovery Sciences, AstraZeneca, Waltham, MA 02451","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036732655","display_name":"Jeffrey W. Johannes","orcid":"https://orcid.org/0000-0001-7242-6682","observed_orcids":["https://orcid.org/0000-0001-7242-6682"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Johannes","raw_affiliation_strings":["Discovery Sciences, AstraZeneca, Waltham, MA 02451"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Sciences, AstraZeneca, Waltham, MA 02451","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052633808","display_name":"Elisabetta Chiarparin","orcid":"https://orcid.org/0000-0002-2998-1346","observed_orcids":["https://orcid.org/0000-0002-2998-1346"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elisabetta Chiarparin","raw_affiliation_strings":["Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049299560","display_name":"Markus Schade","orcid":"https://orcid.org/0000-0002-5538-5767","observed_orcids":["https://orcid.org/0000-0002-5538-5767"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Markus Schade","raw_affiliation_strings":["Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5049299560"],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":null,"apc_paid":null,"fwci":1.0576,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.7259916,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"120","issue":"21","first_page":"e2221967120","last_page":"e2221967120"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.4456000030040741,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.4456000030040741,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.31839999556541443,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.1046999990940094,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/protein-protein-interaction-inhibitors","display_name":"protein-protein interaction inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7490000128746033},{"id":"https://openalex.org/keywords/azd5991","display_name":"AZD5991","score":0.9779999852180481},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.843999981880188},{"id":"https://openalex.org/keywords/hematological-cancer","display_name":"hematologic cancer","score":0.6269999742507935},{"id":"https://openalex.org/keywords/induced-fit","display_name":"induced fit","score":0.8029999732971191},{"id":"https://openalex.org/keywords/conformational-plasticity","display_name":"conformational plasticity","score":0.6629999876022339},{"id":"https://openalex.org/keywords/crystal-structure","display_name":"crystal structure","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.6812430024147034},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.588621973991394},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5586634874343872},{"id":"https://openalex.org/C11804247","wikidata":"https://www.wikidata.org/wiki/Q896177","display_name":"Protein\u2013protein interaction","level":2,"score":0.5358302593231201},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.5039414763450623},{"id":"https://openalex.org/C191120209","wikidata":"https://www.wikidata.org/wiki/Q908902","display_name":"Structural biology","level":2,"score":0.44265204668045044},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.44190654158592224},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.4376303255558014},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4164552390575409},{"id":"https://openalex.org/C18705241","wikidata":"https://www.wikidata.org/wiki/Q1128023","display_name":"Conformational isomerism","level":3,"score":0.4108276069164276},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.36065903306007385},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.27588218450546265},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27577799558639526},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14071810245513916},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0943906307220459},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013141","descriptor_name":"Spiro Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1073/pnas.2221967120","doi":"https://doi.org/10.1073/pnas.2221967120","is_oa":true,"landing_page_url":"https://doi.org/10.1073/pnas.2221967120","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10214187","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10214187","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10214187/pdf/pnas.202221967.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proc Natl Acad Sci U S A","raw_type":"Text"},{"id":"pmid:37186857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37186857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences of the United States of America","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1073/pnas.2221967120","doi":"https://doi.org/10.1073/pnas.2221967120","is_oa":true,"landing_page_url":"https://doi.org/10.1073/pnas.2221967120","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4376643288.pdf","grobid_xml":"https://content.openalex.org/works/W4376643288.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2088883749","https://openalex.org/W2091562724","https://openalex.org/W2105902442","https://openalex.org/W2168166668","https://openalex.org/W2172242534","https://openalex.org/W2181503019","https://openalex.org/W2217901364","https://openalex.org/W2252711380","https://openalex.org/W2343614482","https://openalex.org/W2520043314","https://openalex.org/W2566864171","https://openalex.org/W2791366448","https://openalex.org/W2892573863","https://openalex.org/W2905070646","https://openalex.org/W2906321352","https://openalex.org/W2945338000","https://openalex.org/W2962701388","https://openalex.org/W2992692686","https://openalex.org/W2994953911","https://openalex.org/W3006985196","https://openalex.org/W3014882016","https://openalex.org/W3017304578","https://openalex.org/W3094762523","https://openalex.org/W3096921146","https://openalex.org/W3100043476","https://openalex.org/W3116974172","https://openalex.org/W3183147912","https://openalex.org/W3211299256","https://openalex.org/W4231423004","https://openalex.org/W4282946457"],"related_works":["https://openalex.org/W2156558376","https://openalex.org/W2486438979","https://openalex.org/W2278828177","https://openalex.org/W3024807859","https://openalex.org/W2079979778","https://openalex.org/W4381296213","https://openalex.org/W4250927691","https://openalex.org/W2811096937","https://openalex.org/W2091562724","https://openalex.org/W4294718885"],"abstract_inverted_index":{"The":[0],"structure-based":[1],"design":[2,133],"of":[3,28,69,94],"small-molecule":[4,55],"inhibitors":[5,57,84],"targeting":[6,141],"protein-protein":[7],"interactions":[8],"(PPIs)":[9],"remains":[10],"a":[11,41,97,138],"huge":[12],"challenge":[13],"as":[14],"the":[15,46,66,70,142],"drug":[16],"must":[17],"bind":[18],"typically":[19],"wide":[20],"and":[21,77,86,96],"shallow":[22],"protein":[23,44],"sites.":[24],"A":[25],"PPI":[26,145],"target":[27],"high":[29,92],"interest":[30],"for":[31,140],"hematological":[32],"cancer":[33],"therapy":[34],"is":[35,116],"myeloid":[36],"cell":[37],"leukemia":[38],"1":[39],"(Mcl-1),":[40],"prosurvival":[42],"guardian":[43],"from":[45],"Bcl-2":[47],"family.":[48],"Despite":[49],"being":[50],"previously":[51],"considered":[52],"undruggable,":[53],"seven":[54],"Mcl-1":[56,76,95],"have":[58],"recently":[59],"entered":[60],"clinical":[61,83],"trials.":[62],"Here,":[63],"we":[64],"report":[65],"crystal":[67],"structure":[68],"clinical-stage":[71],"inhibitor":[72],"AMG-176":[73],"bound":[74],"to":[75],"analyze":[78],"its":[79],"interaction":[80],"along":[81],"with":[82],"AZD5991":[85],"S64315.":[87],"Our":[88],"X-ray":[89],"data":[90],"reveal":[91],"plasticity":[93],"remarkable":[98],"ligand-induced":[99],"pocket":[100],"deepening.":[101],"Nuclear":[102],"Magnetic":[103],"Resonance":[104],"(NMR)-based":[105],"free":[106],"ligand":[107],"conformer":[108],"analysis":[109],"demonstrates":[110],"that":[111],"such":[112],"unprecedented":[113],"induced":[114],"fit":[115],"uniquely":[117],"achieved":[118],"by":[119],"designing":[120],"highly":[121],"rigid":[122],"inhibitors,":[123],"preorganized":[124],"in":[125],"their":[126],"bioactive":[127],"conformation.":[128],"By":[129],"elucidating":[130],"key":[131],"chemistry":[132],"principles,":[134],"this":[135],"work":[136],"provides":[137],"roadmap":[139],"largely":[143],"untapped":[144],"class":[146],"more":[147],"successfully.":[148]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-05-17T00:00:00"}